FDA Inspection
Packaging Group CorpPackaging Group Corp – FDA Inspection, Jun 6, 2017
Record Details
This FDA Inspection record concerns Packaging Group Corp, with an inspection on June 6, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9a718b50-04da-4e3c-8827-f3144c200236
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1013016
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.130(c)Lot or control number assigned
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.80(a)Written Procedures Not Followed
- 21 CFR 211.182Written records kept in individual logs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Packaging Group Corp
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 15, 2026 | Not classified | Detroit District Office |
Other documents for Packaging Group Corp
- FDA Inspection 1297854 - 2026-07-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.